Prosecution Insights
Last updated: April 19, 2026

Examiner: PARISI, JESSICA DANIELLE

Tech Center 1600 • Art Units: 1637 1675 1684

This examiner grants 82% of resolved cases

Performance Statistics

81.9%
Allow Rate
+21.9% vs TC avg
127
Total Applications
+22.6%
Interview Lift
1351
Avg Prosecution Days
Based on 83 resolved cases, 2023–2026

Rejection Statute Breakdown

3.7%
§101 Eligibility
24.4%
§102 Novelty
35.7%
§103 Obviousness
21.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17907166 METHOD AND COMPOSITIONS FOR PREPARING NUCLEIC ACID LIBRARIES Non-Final OA Illumina, Inc.
19082018 ANALYSIS OF NUCLEIC ACID SEQUENCES Non-Final OA 10X GENOMICS, INC.
17392610 METHODS AND SYSTEMS FOR PROCESSING POLYNUCLEOTIDES Non-Final OA 10X GENOMICS, INC.
18171045 METHODS AND SYSTEMS FOR SEQUENCE GENERATION AND PREDICTION Non-Final OA REGENERON PHARMACEUTICALS, INC.
18248215 MULTIPLEXED METHYLATED DNA IMMUNOPRECIPITATION SEQUENCING TO STUDY DNA METHYLATION USING LOW AMOUNTS OF DNA Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
17620605 METHODS FOR DUPLEX SEQUENCING OF CELL-FREE DNA AND APPLICATIONS THEREOF Non-Final OA Board of Regents, The University of Texas System
17098912 MAGNETIC CAPTURE BEAD MEDIATED MOLECULAR BARCODING OF NUCLEIC ACID TARGETS IN SINGLE PARTICLES AND COMPOSITIONS FOR USE IN THE SAME Non-Final OA Becton, Dickinson and Company
18139689 METHODS AND COMPOSITIONS FOR CLUSTER GENERATION BY BRIDGE AMPLIFICATION Non-Final OA ILLUMINA CAMBRIDGE LIMITED
18153946 SEQUENCING FROM MULTIPLE PRIMERS TO INCREASE DATA RATE AND DENSITY Non-Final OA Illumina Cambridge Limited
18061333 METHODS AND SYSTEMS FOR DROPLET MANIPULATION Non-Final OA Volta Labs, Inc.
17787900 METHOD FOR IDENTIFYING REGULATORY ELEMENTS CONFORMATIONALLY Non-Final OA ASKBIO INC.
17773333 A METHOD TO PREPARE PERSONALIZED TARGET-IRRELEVANT GUIDE RNA POOL FOR CRISPR Non-Final OA Siemens Healthcare Diagnostics, Inc.
17996196 A METHOD FOR DETECTION OF WHOLE TRANSCRIPTOME IN SINGLE CELLS Non-Final OA SINGLERON (NANJING) BIOTECHNOLOGIES, LTD.
17545724 METHOD AND USE FOR CONSTRUCTION OF SEQUENCING LIBRARY BASED ON DNA SAMPLES Final Rejection MGI TECH CO., LTD.
18249511 METHOD FOR NUCLEIC ACID DETECTION BY OLIGO HYBRIDIZATION AND PCR-BASED AMPLIFICATION Non-Final OA MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT
17920694 SINGLE STEP SAMPLE PREPARATION FOR NEXT GENERATION SEQUENCING Non-Final OA Medicover GmbH
18009149 THREE-DEGREE-OF-FREEDOM LIBRARY PREPARATION CASSETTE AND METHOD USING THE SAME Non-Final OA 3D BIOMEDICINE SCIENCE & TECHNOLOGY CO., LIMITED
17789117 DOUBLE-STRANDED NUCLEIC ACID MOLECULES AND METHOD FOR REMOVING GLASS ADAPTOR IN DNA LIBRARY BY MEANS OF SAME Non-Final OA EONE DIAGNOMICS GENOME CENTER CO., LTD.
17639743 METHOD OF AMPLIFYING MRNAS AND FOR PREPARING FULL LENGTH MRNA LIBRARIES Final Rejection BASECLICK GMBH
17758659 METHODS OF SAMPLE NORMALIZATION Non-Final OA JUMPCODE GENOMICS, INC.
17786012 A LIBRARY OF PREFABRICATED MICROPARTICLES AND PRECURSORS THEREOF Non-Final OA BLINK AG
17292046 3D HUMAN CANCER MODEL-BASED COMBINATORIAL DRUG DEVELOPMENT METHOD Final Rejection PreComb Therapeutics AG
17045775 Method in Bioprocess System Final Rejection Cytiva BioProcess R&D AB
17761696 COMPOSITIONS AND METHODS FOR TEMPLATE-FREE DOUBLE STRANDED GEOMETRIC ENZYMATIC NUCLEIC ACID SYNTHESIS Final Rejection Derek STEMPLE
17685881 METHODS OF ANTIBODY PANNING AGAINST TARGET PROTEINS Final Rejection ALEGRE USA LLC
17681060 METHODS AND SYSTEMS FOR RNA-SEQ PROFILING Non-Final OA Honeycomb Biotechnologies, Inc.
17627678 Internal Standard Gene Final Rejection Public University Corporation Fukushima Medical University
17602712 A LIBRARY OF POLYNUCLEOTIDES Final Rejection Ribbon Biolabs GmbH
17310807 METHODS OF USING MICROFLUIDIC POSITIONAL ENCODING DEVICES Non-Final OA ELEGEN CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month